Sign in

CIK 0001196298

  • Non-accelerated filer
  • Smaller reporting company

NEPHROS INC

Sign in to watch
Ticker
NEPH
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133971809
Phone
+1 201-343-5202
Business address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Option exercise Chief Financial Officer acquired 33,333 shares (option exercise)
  4. 4 Option exercise President and CEO acquired 40,000 shares (option exercise)
  5. 4 Open-market buy President and CEO bought 79,000 shares at $0.45 ($35,550)
  6. 4 Open-market buy Chief Financial Officer bought 80,000 shares at $0.45 ($36,000)
  7. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.48 ($2,375)
  8. 4/A Grant or award Director acquired 73,864 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 73,864 shares (grant or award)
  11. 4 Grant or award Director acquired 73,864 shares (grant or award)
  12. 4 Grant or award Director acquired 113,636 shares (grant or award)
  13. 4 Grant or award Director acquired 73,864 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 120,417 shares (grant or award)
  15. 4 Grant or award President and CEO acquired 180,000 shares (grant or award)
  16. 4 Open-market buy Chief Financial Officer bought 18,333 shares at $0.50 ($9,167)
  17. 4 Open-market buy President and CEO bought 29,580 shares at an average $0.24 ($7,189)
  18. 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $0.27 ($2,712)
  19. 4 Open-market buy President and CEO bought 4,000 shares at $0.25 ($1,000)
  20. 4 Open-market buy President and CEO bought 70,000 shares at $0.26 ($18,200)

Page 7 of 17 · 332 filings